Ocean Biomedical completes SPAC merger; begins trading on Nasdaq under "OCEA"

Ocean Biomedical, Inc.

Completed business combination with Aesther Healthcare Acquisition Corp.; begins trading on Nasdaq on Feb. 15, 2023 under ticker OCEA.
Secured up to $60M backstop from Vellar Opportunity Fund and $75M equity line from White Lion Capital.
Pipeline focused on oncology, pulmonary fibrosis, and infectious disease supported by $123.9M in grants.
Leadership: Elizabeth Ng CEO, Dr. Chirinjeev Kathuria Executive Chairman, Dr. Jack Elias Scientific Advisory Board Chair.
Board of directors includes Suren Ajjarapu, Michael Peterson, Martin D. Angle, Dr. Michelle Berry, Jerome Ringo, Gov. William Owens.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.